Truist Financial Corp cut its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 21.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,259 shares of the company’s stock after selling 7,541 shares during the period. Truist Financial Corp’s holdings in Clorox were worth $3,361,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Stonegate Investment Group LLC lifted its stake in Clorox by 5.2% during the third quarter. Stonegate Investment Group LLC now owns 3,081 shares of the company’s stock worth $380,000 after purchasing an additional 152 shares in the last quarter. Triton Financial Group Inc raised its holdings in shares of Clorox by 2.4% in the 3rd quarter. Triton Financial Group Inc now owns 7,413 shares of the company’s stock valued at $914,000 after buying an additional 173 shares during the period. CFS Investment Advisory Services LLC lifted its stake in Clorox by 5.7% during the 3rd quarter. CFS Investment Advisory Services LLC now owns 2,733 shares of the company’s stock worth $317,000 after acquiring an additional 148 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its holdings in Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after acquiring an additional 10,065 shares during the period. Finally, Cullen Frost Bankers Inc. grew its position in Clorox by 1.3% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 54,526 shares of the company’s stock valued at $6,723,000 after acquiring an additional 693 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox News Summary
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Morgan Stanley raised its price target to $136 and kept an “equal weight” rating, highlighting upside vs. the current share level. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
- Positive Sentiment: Jefferies trimmed its target to $151 but maintained a “buy” rating, signaling continued conviction in the longer-term upside (large percentage upside remains). Jefferies Adjusts Clorox Price Target to $151
- Neutral Sentiment: Clorox will present at the CAGNY conference Feb. 19; management access may provide additional color for investors but is not an immediate earnings driver. Clorox to Present at 2026 CAGNY Conference
- Neutral Sentiment: Company is weighing a potential GOJO deal and completing an ERP integration — strategic moves that could boost long-term positioning but are creating near-term execution/cost uncertainty. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
- Neutral Sentiment: JPMorgan nudged its target to $117 and kept a neutral rating — a minimal change that signals little near-term conviction from that shop. JPMorgan Adjusts Clorox PT to $117
- Neutral Sentiment: TD Cowen raised its target slightly to $111 and maintained a “hold”, a modest signal relative to other shops. TD Cowen Adjusts Clorox Price Target to $111
- Negative Sentiment: Brokerage consensus across several shops shows a tilt toward downgrade/reduction in enthusiasm (a published “Reduce” consensus was flagged), which increases selling pressure. The Clorox Company (NYSE:CLX) Given Consensus Rating of “Reduce” by Brokerages
- Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates, organic sales declined year-over-year and management cited ERP/inventory pressures that are squeezing margins. Clorox Q2 Earnings Miss Estimates, Lower Organic Sales Hurt
- Negative Sentiment: Analysts warn of a near-term profit squeeze from inventory resets and integration costs, a structural headwind for margins in 2026. Clorox Faces Profit Squeeze From Inventory Reset In 2026
- Negative Sentiment: Evercore cut its target to $115 and kept an “underperform” rating, and Deutsche Bank trimmed its target to $112 — additional downward pressure from institutional sellers. Evercore Adjusts Clorox Price Target to $115
Insider Transactions at Clorox
Analysts Set New Price Targets
Several research firms have recently commented on CLX. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. JPMorgan Chase & Co. boosted their target price on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday. Evercore ISI cut their price target on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday. TD Cowen lifted their price objective on Clorox from $108.00 to $111.00 and gave the company a “hold” rating in a research note on Wednesday. Finally, Barclays restated an “underweight” rating and set a $109.00 target price on shares of Clorox in a research note on Friday, January 16th. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $117.93.
View Our Latest Stock Report on Clorox
Clorox Price Performance
CLX stock opened at $117.59 on Friday. The business has a 50 day moving average price of $105.58 and a 200 day moving average price of $114.01. The company has a quick ratio of 0.50, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The stock has a market cap of $14.22 billion, a price-to-earnings ratio of 19.21, a PEG ratio of 0.57 and a beta of 0.59. The Clorox Company has a fifty-two week low of $96.66 and a fifty-two week high of $159.04.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business posted $1.55 EPS. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. Clorox’s dividend payout ratio is 81.05%.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Recommended Stories
- Five stocks we like better than Clorox
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
- [No Brainer Gold Play]: “Show me a better investment.”
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
